TIKR points to retatrutide, due for filing in early 2027, and says a pending Seventh Circuit ruling on whether it counts as a biologic could decide 5 vs 12 years of exclusivity.
Recap by typeshit. Full story at TIKR.com.
She lost 7 kilos in her first month, regained it during a month-long break, and now says she's eating more and gaining in week two back.
A shared report on doctors turning to GLP-1 medications for weight loss in some kids. Details are thin, so tap through for the full story.
The author, who holds Novo shares, cites Morgan Stanley's $190 billion obesity market forecast for 2035 and an NIH-funded mouse study on aging.
The chain says it is exploring concepts including grilled items aimed at GLP-1 users, a sign of how the drugs are shifting food businesses.
She separates FDA-approved drugs from animal-only and internet-hype compounds, from BPC-157 and Epitalon to retatrutide, and stresses that mechanism isn't proof.
BBC Global Women reports on a social media trend of taking weight-loss injections at far lower doses than prescribed.
Loading…